Cargando…

Risk of Liver Fibrosis According to TSH Levels in Euthyroid Subjects

Alterations in thyroid function may contribute to the development of liver fibrosis especially in subjects with non-alcoholic fatty liver disease. This study aimed to investigate the risk of liver fibrosis according to low-normal thyroid function in the general population. We performed a descriptive...

Descripción completa

Detalles Bibliográficos
Autores principales: Martínez-Escudé, Alba, Pera, Guillem, Rodríguez, Lluís, Arteaga, Ingrid, Expósito-Martínez, Carmen, Torán-Monserrat, Pere, Caballería, Llorenç
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8037170/
https://www.ncbi.nlm.nih.gov/pubmed/33805893
http://dx.doi.org/10.3390/jcm10071350
_version_ 1783677080981995520
author Martínez-Escudé, Alba
Pera, Guillem
Rodríguez, Lluís
Arteaga, Ingrid
Expósito-Martínez, Carmen
Torán-Monserrat, Pere
Caballería, Llorenç
author_facet Martínez-Escudé, Alba
Pera, Guillem
Rodríguez, Lluís
Arteaga, Ingrid
Expósito-Martínez, Carmen
Torán-Monserrat, Pere
Caballería, Llorenç
author_sort Martínez-Escudé, Alba
collection PubMed
description Alterations in thyroid function may contribute to the development of liver fibrosis especially in subjects with non-alcoholic fatty liver disease. This study aimed to investigate the risk of liver fibrosis according to low-normal thyroid function in the general population. We performed a descriptive cross-sectional study in subjects from 18–75 years randomly selected from 16 primary health care centers from 2017–2019. Each subject underwent clinical evaluation, physical examination, blood analysis and transient hepatic elastography. Descriptive and multivariate logistic regression analyses were used to identify factors associated with fibrosis. We included 1096 subjects (60 ± 11 years; 61% women); 70% had strict-normal thyroid function and 30% had low-normal thyroid function. Low-normal thyroid function was associated with a higher liver stiffness (LS) values: 5.2 vs. 4.8 kPa (p = 0.001) and a greater prevalence of fibrosis: 6.1 vs. 3% (p = 0.016) and 4.3 vs. 2.1% (p = 0.044) for the cut-off points of ≥8.0 kPa and ≥9.2 kPa, respectively. After adjustment for potential confounding factors, the risk of fibrosis in subjects with low-normal thyroid function was OR 1.54 (p = 0.213). In conclusion, low-normal thyroid function is associated with higher LS values and a greater risk of liver fibrosis in the general population, being dependent on other metabolic factors.
format Online
Article
Text
id pubmed-8037170
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-80371702021-04-12 Risk of Liver Fibrosis According to TSH Levels in Euthyroid Subjects Martínez-Escudé, Alba Pera, Guillem Rodríguez, Lluís Arteaga, Ingrid Expósito-Martínez, Carmen Torán-Monserrat, Pere Caballería, Llorenç J Clin Med Article Alterations in thyroid function may contribute to the development of liver fibrosis especially in subjects with non-alcoholic fatty liver disease. This study aimed to investigate the risk of liver fibrosis according to low-normal thyroid function in the general population. We performed a descriptive cross-sectional study in subjects from 18–75 years randomly selected from 16 primary health care centers from 2017–2019. Each subject underwent clinical evaluation, physical examination, blood analysis and transient hepatic elastography. Descriptive and multivariate logistic regression analyses were used to identify factors associated with fibrosis. We included 1096 subjects (60 ± 11 years; 61% women); 70% had strict-normal thyroid function and 30% had low-normal thyroid function. Low-normal thyroid function was associated with a higher liver stiffness (LS) values: 5.2 vs. 4.8 kPa (p = 0.001) and a greater prevalence of fibrosis: 6.1 vs. 3% (p = 0.016) and 4.3 vs. 2.1% (p = 0.044) for the cut-off points of ≥8.0 kPa and ≥9.2 kPa, respectively. After adjustment for potential confounding factors, the risk of fibrosis in subjects with low-normal thyroid function was OR 1.54 (p = 0.213). In conclusion, low-normal thyroid function is associated with higher LS values and a greater risk of liver fibrosis in the general population, being dependent on other metabolic factors. MDPI 2021-03-25 /pmc/articles/PMC8037170/ /pubmed/33805893 http://dx.doi.org/10.3390/jcm10071350 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ).
spellingShingle Article
Martínez-Escudé, Alba
Pera, Guillem
Rodríguez, Lluís
Arteaga, Ingrid
Expósito-Martínez, Carmen
Torán-Monserrat, Pere
Caballería, Llorenç
Risk of Liver Fibrosis According to TSH Levels in Euthyroid Subjects
title Risk of Liver Fibrosis According to TSH Levels in Euthyroid Subjects
title_full Risk of Liver Fibrosis According to TSH Levels in Euthyroid Subjects
title_fullStr Risk of Liver Fibrosis According to TSH Levels in Euthyroid Subjects
title_full_unstemmed Risk of Liver Fibrosis According to TSH Levels in Euthyroid Subjects
title_short Risk of Liver Fibrosis According to TSH Levels in Euthyroid Subjects
title_sort risk of liver fibrosis according to tsh levels in euthyroid subjects
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8037170/
https://www.ncbi.nlm.nih.gov/pubmed/33805893
http://dx.doi.org/10.3390/jcm10071350
work_keys_str_mv AT martinezescudealba riskofliverfibrosisaccordingtotshlevelsineuthyroidsubjects
AT peraguillem riskofliverfibrosisaccordingtotshlevelsineuthyroidsubjects
AT rodriguezlluis riskofliverfibrosisaccordingtotshlevelsineuthyroidsubjects
AT arteagaingrid riskofliverfibrosisaccordingtotshlevelsineuthyroidsubjects
AT expositomartinezcarmen riskofliverfibrosisaccordingtotshlevelsineuthyroidsubjects
AT toranmonserratpere riskofliverfibrosisaccordingtotshlevelsineuthyroidsubjects
AT caballeriallorenc riskofliverfibrosisaccordingtotshlevelsineuthyroidsubjects